RE: 201 data25 Apr 2020 12:27
EyeGuy, I think you are right in the sense that the situation has changed and so old narratives warning of investing in ValiRx have to reconsidered. Getting rid of two problem directors had given a certain confidence and that this is reflected in two PIs taking on major holdings in the company this week. I also think that this is a high risk share, but I don't think there is any evidence that translates into high reward. One thing that does concern me is that the two compounds that are most developed Val 201 and 401 have been kicking around for years now. I just don't know if they will still be relevant. Fingers crossed they are, but I would prefer to remain moderately optimistic. Its also great that Val 101 and 301 are there, but being in early development, its too early to praising from the roof tops, again grounds to be optimistic, but I recommend keeping feet on the ground. The legacy of George and Satu is such that we are not out of the woods, but I look at this as early days even thought I have been holding this since 2012.